The Infectious Diseases Data Observatory (IDDO) is a scientifically independent, multi-disciplinary coalition of the global infectious disease and emerging infections communities. It provides the methods, governance and infrastructure to translate data into evidence that improves outcomes for patients worldwide. Currently, IDDO has eight active areas of research with many more already in development or being scoped for feasibility.
Share data

If you work with clinical, laboratory or epidemiological data and want to share your research or access research data then you are welcome to sign up to the Observatory.

We have platforms for a range of diseases including emerging and neglected infections.

Learn about our approach and governance
Learn about our research themes
What is IDDO?

The Infectious Diseases Data Observatory (IDDO) is a researcher driven network which provides data platforms to capture, share and collaborate on infectious disease related data.

Using years of experience and extensive investment in data tools we provide platforms which are designed for effective data analysis and robust governance.

Find out more about IDDO

COVID-19

Explore our work on COVID-19

Sars cov2 causes covid19
View

Research themes

IDDO enables research-driven responses to major challenges of infectious diseases through development and management of data sharing platforms.

Credit: Wellcome Images
Research themes

Contributing data

Learn more about sharing your data through IDDO

Connected world
Contribute data

Tools and resources

IDDO is committed to providing practical tools and services to support the collection of disease characterisation data and develop quality evidence on optimal treatment and response to emerging infections. 

Credit: MORU
View our resources

News

astmh-2017-ccvtm-wwarn-stand.jpg
News Article
24 Oct 2018
ASTMH 2018 has begun – discover our activities in New Orleans
mqph_audi9ence_websize.jpg
News Article
23 Oct 2018
Sparking new collaboration and multi-stakeholder discussion on substandard and falsified medicines at MQPH 2018
ninth-edctp-forum_31481078178_o.jpg
News Article
22 Oct 2018
Highlights from the 9th EDCTP Forum in Lisbon
mqph-2018-iddo-stand-visitor.jpg
News Article
23 Sep 2018
First ever international conference on Medicine Quality and Public Health this month
View all news items

Latest publications

Enhanced effect of seasonal malaria chemoprevention when coupled with nutrients supplementation for preventing malaria in children under 5 years old in Burkina Faso: a randomized open label trial

Malaria Journal

Published: 26 Oct 2023

Author(s): Paul Sondo, Bérenger Kaboré, Toussaint Rouamba, Eulalie Compaoré, Yssimini Nadège Guillène Tibiri, Hyacinthe Abd-El Latif Faïçal Kaboré, Karim Derra, Marc Christian Tahita, Hamidou Ilboudo, Gauthier Tougri, Ismaïla Bouda, Tikan

DOI: https://doi.org/10.1186/s12936-023-04745-6

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Malaria Journal

Published: 10 Oct 2023

Author(s): Parinaz Mehdipour, Megha Rajasekhar, Saber Dini, Sophie Zaloumis, Tesfay Abreha, Ishag Adam, Ghulam Rahim Awab, J. Kevin Baird, Larissa W. Brasil, Cindy S. Chu, Liwang Cui, André Daher, Margarete do Socorro M Gomes, Lilia Gonzalez‑Ceron, Jimee Hwang, , Harin Karunajeewa, Marcus V. G. Lacerda, Simone Ladeia-Andrade, Toby Leslie, Benedikt Ley, Kartini Lidia, Alejandro Llanos-Cuentas, Rhea J. Longley, Wuelton Marcelo Monteiro, Dhelio B. Pereira, Komal Raj Rijal, Kavitha Saravu, , Inge Sutanto, Walter R. J. Taylor, Pham Vinh Thanh, Kamala Thriemer, José Luiz F. Vieira, Nicholas J. White, Lina M. Zuluaga-Idarraga, Philippe J. Guerin, Ric N. Price, Julie A. Simpson, Robert J. Commons on behalf of the WWARN Vivax Adherence Study Group

DOI: https://doi.org/10.1186/s12936-023-04725-w

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

The Lancet Infectious Diseases

Published: 22 Sep 2023

Author(s): Megha Rajasekhar, Prof Julie A Simpson, Benedikt Ley, Peta Edler, Cindy S Chu, Tesfay Abreha, Ghulam R Awab, Prof J Kevin Baird, Germana Bancone, Bridget E Barber, Matthew J Grigg, Jimee Hwang, Harin Karunajeewa, Prof Marcus V G Lacerda, , Simone Ladeia-Andrade, Prof Alejandro Llanos-Cuentas, Prof Sasithon Pukrittayakamee, Komal R Rijal, Kavitha Saravu, Prof Inge Sutanto, Walter R J Taylor, Kamala Thriemer, James A Watson, Prof Philippe J Guerin, Prof Nicholas J White, Prof Ric N Price, Rob, on behalf of theWorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group

DOI: https://doi.org/10.1016/S1473-3099(23)00431-0

View all publications